The first quarter for the skewed 2021/2022 financial year will be marked by a difficult basis of comparison and continued logistical challenges, both of which will put a damper on the report, says Søren Løntoft Hansen, senior equity analyst at Danish bank Sydbank, prior to the report’s release on February 8.
”Ambu’s first quarter will be characterized by a difficult basis of comparison within its Visualization business. Add to this continued logistic challenges in Ambu’s core business, which will, in our assessment, dampen growth in the quarter. We estimate a total organic growth of 1 percent, while a positive currency effect will lift up revenue,” the analyst writes.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Key Account Manager, Europe and Asia 
Biomarker Operations Lead 
Clinical Trial Manager 
SAP System Specialist (Product Supply) – Business Application Services 
Vice President, Test & Characterisation 
Director Global Engineering 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Project Manager & Scrum Master 
Consultant Manager 
Biostatistician 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Nordic Medical Affairs Manager 
Client Talent Acquisition Specialist 
Account Manager 
Senior Manager, Clinical Trial Budget